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Rationale: Chronic obstructive pulmonary disease is a leading cause
of death worldwide, but its pathogenesis is not well understood.
Previous studies have shown that airway surface dehydration in
b-epithelial Na1 channel (bENaC)–overexpressing mice caused a
chronic lung disease with high neonatal pulmonary mortality and
chronic bronchitis in adult survivors.
Objectives: The aim of this study was to identify the initiating lesions
and investigate the natural progression of lung disease caused by
airway surface dehydration.
Methods: Lung morphology, gene expression, bronchoalveolar la-
vage, and lung mechanics were studied at different ages in bENaC-
overexpressing mice.
Measurements and Main Results: Mucus obstruction in bENaC-
overexpressing mice originated in the trachea in the first days of
life and was associated with hypoxia, airway epithelial necrosis, and
death. In surviving bENaC-overexpressing mice, mucus obstruction
extended into the lungs and was accompanied by goblet cell meta-
plasia, increased mucin expression, and airway inflammation with
transient perinatal increases in tumor necrosis factor-a and macro-
phages, IL-13 and eosinophils, and persistent increases in keratinocyte-
derived cytokine (KC), neutrophils, and chitinases in the lung. bENaC-
overexpressing mice also developed emphysema with increased lung
volumes, distal airspace enlargement, and increased lung compliance.
Conclusions: Our studies demonstrate that airway surface dehydration
is sufficient to initiatepersistent neutrophilic airway inflammation with
chronic airways mucus obstruction and to cause transient eosinophilic
airway inflammation and emphysema. These results suggest that
deficient airway surface hydration may play a critical role in the
pathogenesis of chronic obstructive pulmonary diseases of different
etiologies and serve as a target for novel therapies.
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Cystic fibrosis (CF) lung disease is the most common genetic
form of chronic obstructive pulmonary disease (COPD) and is
caused by mutations in the cystic fibrosis transmembrane con-
ductance regulator (CFTR) gene (1, 2), which encodes a protein
that is a cAMP-dependent Cl2 channel and regulates the epithe-
lial Na1 channel (ENaC) (3–6). In CF airway epithelia, CFTR-
mediated Cl2 secretion is defective, and ENaC-mediated Na1
absorption is increased (7–9). In vitro studies of primary human
airway cultures suggested that these defects in vectorial ion trans-
port resulted in airway surface liquid (ASL) volume depletion
and adhesion of dehydrated mucus, which was predicted to im-
pair normal ciliary function and efficient mucus clearance in CF
airways (10). To further elucidate the role of ASL volume de-
pletion in the in vivo pathogenesis of CF, we have previously
generated a mouse model with airway-specific overexpression of
ENaC (11). In this mouse model, we demonstrated (1) that over-
expression of the b-subunit of ENaC (encoded by the Scnn1b
gene) under control of the Clara cell secretory protein (CCSP)
promoter was sufficient to increase airway Na1 absorption in vivo,
(2) that elevated airway Na1 absorption caused ASL volume
depletion and reduced mucus clearance, and (3) that deficient
mucus clearance produced spontaneous lung disease sharing key
features with CF and other forms of COPD, including substantial
pulmonary mortality and airway mucus obstruction, goblet cell
metaplasia, chronic neutrophilic inflammation, and impaired clear-
ance of bacterial pathogens (11).
Together, the results from these in vitro and in vivo studies
demonstrate that ASL volume depletion is a key mechanism in
the pathogenesis of CF lung disease. Furthermore, cigarette
smoke has recently been shown to decrease CFTR expression
and cAMP-dependent Cl2 secretion in vitro and in nasal res-
piratory epithelia of cigarette smokers in vivo (12). These data
indicate that impaired ASL volume regulation may also be im-
plicated in the pathogenesis of cigarette smoke–induced chronic
bronchitis. The aim of the present study was to define the initial
pulmonary lesions and elucidate the sequence of steps in the
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Airway surface dehydration is a key feature of cystic fibrosis
and produces chronic bronchitis in mice. The initiating
lesions and the natural history of lung disease caused by
airway surface dehydration have not been elucidated.
What This Study Adds to the Field
Airway surface dehydration is sufficient to initiate persistent
neutrophilic airway inflammation with chronic airways mucus
obstruction and to cause transient eosinophilic airway in-
flammation and emphysema. These results suggest that de-
ficient airway surface hydration may play a critical role in the
pathogenesis of chronic obstructive pulmonary diseases of
different etiologies and serve as a target for novel therapies.
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in vivo pathogenesis of COPD consequent to airway surface
dehydration in bENaC-overexpressing mice. A focus was on the
relationships between ASL volume depletion and mucus ob-
struction, the presumed cause of mortality in this model. To
achieve this goal, we performed quantitative longitudinal stud-
ies from fetal to adult ages of the pulmonary phenotype, in-
cluding airway mucus obstruction, goblet cell metaplasia, mucin
gene expression, airway inflammation, lung volume, alveolar
size, and pulmonary function. The results of our studies yielded
novel insights into the role of airway surface dehydration in the
in vivo pathogenesis of CF and possibly other forms of COPD
and identified targets for novel therapeutic strategies for the
treatment of these diseases. Some of the results of this study
have been previously reported in the form of abstracts (13, 14).
METHODS
Experimental Animals
All animal studies were approved by the animal care and use committees
of the relevant institutions. The generation of bENaC-overexpressing
mice (line 6608) has been described previously (11). Further details on
experimental animals are provided in the online supplement.
Bronchoalveolar Lavage Cell Counts and
Cytokine Measurements
Bronchoalveolar lavage (BAL) was obtained and cell counts were de-
termined as previously described (11). Macrophage size was deter-
mined as described in the online supplement. Concentrations of tumor
necrosis factor (TNF)-a, keratinocyte-derived cytokine (KC), and IL-
13 were measured by ELISA (R&D Systems, Minneapolis, MN) or
with a Cytometric Bead Array Mouse Inflammation kit (BD Bio-
sciences, San Diego, CA).
Morphology
Lungs and tracheae were fixed, paraffin embedded, sectioned, and stained
with hematoxylin and eosin (H&E) or Alcian blue periodic acid-Schiff as
previously described (11). For transmission electron microscopy (TEM)
studies, lungs were fixed and processed, and ultrastructural tissue exam-
ination was performed as described in the online supplement.
Airway Morphometry
Tracheae were sectioned longitudinally, and lungs were sectioned trans-
versally at the level of the proximal intrapulmonary main axial airway
near the hilus and at the distal intrapulmonary axial airway. Airway
mucus obstruction was assessed by determining mucus volume density as
previously described (15). Airway epithelial glycogen content, epithelial
height, and numeric cell densities of goblet cells and degenerative airway
epithelial cells were determined as described in the online supplement.
Lung Volume and Mean Linear Intercepts
Lungs were inflated with 4% buffered formalin to 25 cm of fixative
pressure, and lung volumes were determined by the volume displace-
ment method (16). Lungs were processed for histology, sectioned, and
stained with H&E. Mean linear intercepts were determined as previously
described (17). Further details are provided in the online supplement.
Immunohistochemistry
Immunohistochemical staining for Ym1 was performed on formalin-
fixed, paraffin-embedded lung sections using rabbit polyclonal anti-
Ym1 antibody (18) as described in the online supplement.
Hypoxia Detection in the Lung
Tissue hypoxia was assessed by intraperitoneal injection of 3-d-old
neonatal mice with pimonidazole hydrochloride (Hypoxyprobe-1;
Chemicon, Temecula, CA) and immunostaining of frozen lung sections
using fluorescein isothiocyanate–labeled monoclonal antibody (MAb) 1
(Hypoxyprobe-1 Plus Kit; Chemicon) as described in the online sup-
plement.
Blood Gas Analyses
Blood gas measurements in neonatal mice (3–5 d) were performed
using a blood gas analyzer (Radiometer ABL 500; Diamond Diagnos-
tics, Holliston, MA) as described in the online supplement.
Western Blotting
Acidic mammalian chitinase (AMCase) protein expression was assessed
in cell-free BAL fluid (BALF) from bENaC-overexpressing mice and
wild-type littermates by Western blotting using an anti-AMCase rabbit
serum (19) as described in the online supplement.
Real-time Reverse Transcriptase–Polymerase Chain Reaction
Quantitative reverse transcriptase–polymerase chain reaction for Muc5ac,
Muc5b, Muc4, Gob5, eotaxin-1, IL-13, IFN-g, Ym1, Ym2, AMCase,
and b-actin was performed on an Applied Biosystems 7500 Real Time
PCR System using TaqMan universal polymerase chain reaction
master mix and inventoried TaqMan gene expression assays (Applied
Biosystems, Darmstadt, Germany) as described in the online supple-
ment. Relative fold changes in target gene expression between bENaC-
overexpressing mice and wild-type littermates were determined by
normalization to expression of the reference gene b-actin as previously
described (20).
Pulmonary Function Studies
Invasive measurements of lung mechanics were performed in anesthe-
tized and paralyzed 8-week-old adult mice using a computer-controlled
small animal ventilator (Flexi Vent system; Scireq, Montreal, PQ, Canada)
to determine dynamic resistance, dynamic compliance, pressure–
volume curves, and static compliance of the lung, as previously de-
scribed (21, 22).
Statistics
Data were analyzed with SigmaStat version 3.1 (Systat Software, Erkrath,
Germany) and are reported as mean 6 SEM. Statistical analyses were
performed using Student’s t test, Mann-Whitney rank sum test, one-way
analysis of variance, Kruskal-Wallis analysis of variance on Ranks, or
chi-square test as appropriate, and P , 0.05 was accepted to indicate
statistical significance.
RESULTS
ASL Volume Depletion–induced Mucus Obstruction, Goblet
Cell Metaplasia, and Mucus Hypersecretion
To identify the onset and temporal evolution of goblet cell meta-
plasia, mucus hypersecretion, and mucus obstruction caused by
ASL volume depletion, we performed longitudinal morphomet-
ric studies and studies on airway mucin expression in fetal
(Embryonic Day [E] 18.5), newborn (Postnatal Day [PN] 0.5),
neonatal (PN 3.5), juvenile (1–3 wk of age), and adult (6 wk of
age) bENaC-overexpressing mice and littermate control mice.
The onset of mortality in bENaC-overexpressing mice com-
menced at 3 d of age with an overall mortality of approximately
50% in the first 2 weeks of life (Figure 1A). Compared with
wild-type (Figure 1B), mortality at 3 days was associated with
light microscopic evidence of tracheal plugging (Figures 1C and
1D), increased mucus volume density (Figure 1E), and mucus
plugging of the larynx (Figure 1F) but not goblet cell metaplasia
(Figure 1G). The extent of tracheal and laryngeal mucus ob-
struction was significantly more severe in age-matched deceased
compared with bENaC-overexpressing mice killed as part of
this study (Figure 1F), indicating that death occurred due to
mucus obstruction of the glottis and subsequent asphyxia. In
contrast, neither intrapulmonary airway mucus obstruction nor
goblet cell metaplasia were detected in the lungs from fetal,
newborn (data not shown), or neonatal (PN 3.5) bENaC-
overexpressing mice (Figures 2A, 2G, and 2I).
In 2-week-old surviving bENaC-overexpressing mice, intra-
luminal mucus plugging extended into intrapulmonary airways
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(Figure 2). Mucus obstruction was most prominent in proximal
intrapulmonary main axial airways (large-diameter bronchiole;
Figures 2B and 2G) but also extended into the more distal
conducting airways (small-diameter, preterminal bronchioles;
Figures 2C and 2H) and persisted in 3- and 6-week-old bENaC-
overexpressing mice (Figures 2D, 2E, 2G, and 2H). In contrast
to early tracheal mucus plugging, intrapulmonary airway mucus
obstruction was accompanied by goblet cell metaplasia in
bENaC-overexpressing mice. Wild-type mice exhibited a tran-
sient increase in airway goblet cell numbers that peaked at 2
weeks of age, persisted in proximal main axial airways (large-
diameter bronchioles), and waned in the more distal small-
diameter bronchioles of adult animals (Figures 2I and 2J). In
bENaC-overexpressing mice, goblet cell numbers were signifi-
cantly increased in proximal large-diameter bronchioles at the
age of 3 and 6 weeks and in distal small-diameter bronchioles at
all time points (Figures 2I and 2J). The onset of goblet cell meta-
plasia in 2-week-old bENaC-overexpressing mice was paral-
leled by epithelial cell hypertrophy with epithelial thickening
that persisted in adult animals (Figure 2K).
To explore the relationship between mucus obstruction and
goblet cell metaplasia with mucin expression, we determined
mRNA transcript levels of the airway mucins Muc5ac, Muc5b,
and Muc4 and the goblet cell marker Gob-5 (Clca-3) in lungs
from newborn to adult bENaC-overexpressing mice and control
mice. In wild-type mice, expression of Muc5ac and Gob-5 was
significantly elevated at the age of 1 week, and expression of
Muc5b and Muc4 was significantly elevated at the age of 3 weeks
when compared with newborn mice (Figures 3A–3D). Although
induction of Muc5ac, Muc4, and Gob-5 was transient, with peak
levels at 1 and 3 weeks, expression of Muc5b remained elevated
in adult wild-type mice (Figures 3A–3D). In bENaC-overexpressing
mice, mRNA expression levels of Muc5ac, Muc5b, Muc4, and
Gob-5 followed similar time courses and were significantly in-
creased compared with control mice from the age of 3 weeks
onward (Figures 3A–3D).
Taken together, these data demonstrate that ASL volume de-
pletion caused airway mucus obstruction, goblet cell metaplasia,
and increased mucin gene expression in an age-dependent fash-
ion. In the first week of life, airway Na1 hyperabsorption caused
tracheal mucus plugging and high mortality in the absence of gob-
let cell metaplasia and elevated mucin gene expression (Figures
1–3). Subsequently, in surviving bENaC-overexpressing mice,
mucus obstruction extended into intrapulmonary airways and
was accompanied by secondary goblet cell metaplasia and in-
creased mucin expression (Figures 2 and 3).
Mucus Obstruction Causes Hypoxia
Because histologic evaluation identified tracheal mucus obstruc-
tion in a large fraction of bENaC-overexpressing mice as early
as 3 days (see Figures 1C–1F) and because the majority of deaths
in bENaC-overexpressing mice occurred in the first week of life
(see Figure 1A), we performed blood gas analyses in neonatal
mice (PN 3.5–5.5) to determine the effects of tracheal mucus
plugging on ventilation. These analyses showed that PO2, oxygen
saturation, and base excess were significantly reduced in blood
samples from bENaC-overexpressing mice compared with wild-
type littermates (Table 1). These results demonstrate that tracheal
mucus plugging was sufficient to cause systemic hypoxia. Re-
duced base excess, in parallel with hypoxia, suggested metabolic
compensation of respiratory alkalosis, indicating that respiratory
insufficiency was a chronic process in bENaC-overexpressing
mice.
Airway Na1 Hyperabsorption and Epithelial Necrosis
High-resolution light and TEM studies revealed that airway
Na1 hyperabsorption was accompanied by early airway epithe-
lial degeneration and necrosis in the intralobular airways but
not in the trachea (Figure 4). Swollen, highly vacuolated, degen-
erative airway epithelial cells were observed in high numbers in
neonatal bENaC-overexpressing mice but rarely in wild-type
control mice (Figures 4A and 4B). In bENaC-overexpressing
mice, degenerative epithelial cells were absent in the fetus (E
18.5; data not shown), present in newborn mice (PN 0.5), peaked
at the age of 3 days, and were rarely observed in the airways of
older bENaC-overexpressing animals (Figure 4C). Furthermore,
the intraepithelial content of PAS-positive material was reduced
in newborn bENaC-overexpressing mice, indicating a reduction
in airway epithelial glycogen content compared with wild-type
Figure 1. Pulmonary mortality and tracheal mucus obstruction in
b-epithelial Na1 channel (bENaC)–overexpressing mice. (A) Survival
curves from bENaC-overexpressing mice (circles; n 5 35) and wild-type
littermates (triangles; n 5 36). (B–D) Histology (Alcian blue periodic
acid-Schiff) of tracheae from wild-type (B) and bENaC-overexpressing
mice (C) killed at the age of 3 days and a bENaC-overexpressing mouse
that died spontaneously at 4 days (D). Larynx is indicated by arrows.
Scale bars, 1,000 mm. Representative for n 5 6–14 mice per group. (E–
G) Summary of tracheal mucus content as determined from volume
density measurements (E), frequency of laryngeal mucus plugging (F),
and goblet cell counts (G) in tracheae from wild-type (open bars),
bENaC-overexpressing mice killed at 3 days (shaded bars), and bENaC-
overexpressing mice that died spontaneously at the ages of 3 to 7 days
(solid bars). n 5 11 – 16 mice per group. *P , 0.001 versus wild-type.
†P , 0.01 versus killed bENaC-overexpressing mice.
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control mice (Figure 4D). Ultrastructural examination by TEM
identified abnormalities in Clara cells but not in ciliated cells.
These abnormalities included depletion of epithelial glycogen
stores and vacuolarization of the endoplasmatic reticulum, in-
dicative of hydropic degeneration of Clara cells in newborn
bENaC-overexpressing but not wild-type mice (Figures 4E and
4F). Compared with wild-type mice (Figure 4G), the majority of
degenerative Clara cells of 3-day-old bENaC-overexpressing
mice had pyknotic nuclei (Figure 4H), and immunostaining for
activated caspase 3 as a marker for apoptosis was negative (data
not shown), indicating that these cells underwent necrosis.
To assess a possible role of tissue hypoxia in airway epithelial
necrosis, 3-day-old mice were treated with the hypoxia probe
pimonidazole hydrochloride, and lung sections were subse-
quently evaluated by immunofluorescence using monoclonal
antibodies that detect protein adducts of this probe in hypoxic
cells. Strong immunoreactive signals were detected in the air-
way epithelium of bENaC-overexpressing mice but not in wild-
type littermates (Figure 5). Immunoreactive signals were not
detected in alveolar epithelia or in lungs from mice that were
not treated with the hypoxia probe in either genotype. These
data demonstrate that airway epithelial cells were hypoxic in
neonatal bENaC-overexpressing mice and suggest that Clara
cell necrosis resulted from cellular hypoxia.
Taken together, these data demonstrate that Na1 hyper-
absorption induced by CCSP promoter–driven overexpression
of bENaC resulted in neonatal depletion of glycogen stores,
cellular hypoxia, hydropic degeneration, and necrosis of Clara
cells. Degenerative and/or necrotic cells were not observed in
mouse airways where CCSP promoter-driven overexpression of
transgenes did not result in Na1 hyperabsorption (11) (i.e., in
aENaC- and gENaC-overexpressing mice; data not shown). In
bENaC-overexpressing mice, necrotic Clara cells were sub-
sequently cleared from the airways and replaced by Clara cells
and goblet cells in juvenile and adult bENaC-overexpressing
mice (see Figures 2B–2E, 4C).
Figure 2. Development of airway
mucus obstruction, goblet cell
metaplasia, and epithelial hyper-
plasia in b-epithelial Na1 channel
(bENaC)–overexpressing mice. (A–
D) Lung histology (Alcian blue
periodic acid-Schiff) from bENaC-
overexpressing mice that were
killed at 3 days (A), 2 weeks (B,
C), and 6 weeks (D, E) of age and
from a 2-week-old wild-type con-
trol mouse (F). Lungs were sec-
tioned at the level of the proximal
(B, D) main axial airway and from
the distal axial airway (E, F). Scale
bars, 100 mm. Representative for
n 5 6–14 mice per group. (G–K)
Summary of airway mucus ob-
struction, goblet cell counts, and
epithelial height in bronchi from
wild-type (open bars) and bENaC-
overexpressing mice (solid bars) at
3 days, 2 weeks, 3 weeks, and 6
weeks of age. n 5 6–10 mice per
group. (G) Mucus content in prox-
imal main axial airways. *P , 0.01
versus littermate control mice at
same age; †P , 0.05 versus 3-day-
old and 3-week-old wild-type
mice; ‡P , 0.05 versus 3-day-old
bENaC-overexpressing mice. (H)
Mucus content in distal axial air-
ways. *P , 0.05 versus wild-type
mice of same age. (I) Goblet cell
counts in proximal main axial air-
ways. *P , 0.05 versus wild-type
mice of same age; †P , 0.05
versus 3-day-old mice of same
genotype. (J) Goblet cell counts
in distal axial airways. *P , 0.02
versus wild-type mice of same
age; †P , 0.05 versus 2-week-old
mice of same genotype. (K) Epi-
thelial height in lobar bronchi.
*P , 0.02 versus wild-type mice.
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Development of Chronic Airway Inflammation
In histologic lung sections, necrotic lesions in the airways of
neonatal bENaC-overexpressing mice were accompanied by
acute cellular inflammation of large- and small-diameter bron-
chioles (bronchiolitis), consisting of intramural and intraluminal
infiltration of neutrophils and airway luminal macrophages
engulfing necrotic cellular debris. To study the evolution of
airway inflammation, we performed longitudinal BAL studies in
5-day-old to adult mice and measured the absolute numbers and
relative distributions of different inflammatory cell types (Fig-
ure 6). BAL macrophages were significantly increased at 5 days
and 2 weeks and were normalized in numbers but remained
morphologically activated (i.e., hypertrophic cells with highly vac-
ulolated cytoplasm) in 3- and 6-week-old bENaC-overexpressing
mice compared with control mice (Figures 6B, 6G–6I). Neutro-
phils were recruited in parallel with macrophages, peaked at 5
days, and remained significantly elevated at all time points in
bENaC-overexpressing mice (Figure 6C). Two- to three-week-old
wild-type mice exhibited a transient airway eosinophilia that
waned in adult mice, as previously reported (23). Eosinophilia
was significantly increased in bENaC-overexpressing mice. In con-
trast to persistent neutrophilic inflammation, eosinophilia waned
in adult bENaC-overexpressing animals (Figure 6D). Lymphocyte
counts tended to be higher in bENaC-overexpressing mice than in
control mice, but a significant difference was only observed in
adult animals (Figure 6E).
We determined protein and/or mRNA expression of proin-
flammatory cytokines, including TNF-a, KC (Cxcl1), eotaxin-1
(Ccl11), IL-13, and IFN-g in BAL or lung homogenates from
newborn to adult bENaC-overexpressing mice and control mice
(Figure 7). None of the cytokines was elevated in fetal (E 18.5)
or newborn (PN 0.5) bENaC-overexpressing mice compared
with wild-type littermates. TNF-a was transiently elevated in
BAL from bENaC-overexpressing mice, with peak levels in
neonatal mice (i.e., at the age when necrotic lesions were most
prominent) (Figures 4C and 7A). The neutrophil-attracting che-
mokine KC was significantly elevated in bENaC-overexpressing
mice from the first week of life, and increased KC levels were
sustained into adulthood (Figure 7B). Expression of the eosin-
ophil-attracting chemokine eotaxin 1 was increased in bENaC-
overexpressing mice, but the fold increase over wild-type mice
was less pronounced than KC expression (Figure 7C). mRNA
expression of the Th2 cytokine IL-13 was transiently induced in
neonatal wild-type mice and waned in older animals, indicating
that wild-type animals were Th2 biased during development
(24) (Figure 7E). In bENaC-overexpressing mice, IL-13 mRNA
expression followed the same time course but was significantly
increased at all time points compared with control mice. Sig-
nificantly elevated IL-13 protein levels were observed in 2- to
3-week old mice but not in adult bENaC-overexpressing mice
(Figures 7D and 7E). In contrast, mRNA expression of the Th1
cytokine IFN-g increased with age in wild-type and bENaC-
overexpressing mice but did not differ between genotypes at any
time point (Figure 7F). Taken together, the transient elevation
of IL-13, followed by sustained elevation of IFN-g mRNA ex-
pression, indicated a shift from Th2 toward Th1 response during
normal development (24).
Airway Inflammation Is Associated with Expression
of Chitinases
In airway mucus plugs of bENaC-overexpressing mice, we fre-
quently observed eosinophilic crystalline material (Figure 8A)
similar to that identified as the crystallized product of various
members of mammalian chitinase family, including Ym1, Ym2,
and AMCase (18, 19, 25, 26). Immunohistochemically, Ym1-
positive staining was present in the crystals and in the luminal
airway mucus of bENaC-overexpressing mice but not in control
mice (Figures 8B and 8C). Positive Ym1 immunostaining was
also observed in nonciliated airway epithelial cells (mainly
mucous cells) lining proximal large-diameter bronchiolar airways
and in macrophages within distal and proximal airway lumens
and alveolar airspaces. In contrast, in wild-type littermates, Ym1
protein expression was confined to alveolar macrophages. By
TEM, acicular (needle-shaped) crystals were identified in the
cytoplasm of macrophages (Figure 8D). Immunohistochemical
Figure 3. Time course of airway mucin expression in b-epithelial Na1
channel (bENaC)–overexpressing mice. (A–D) Transcripts levels of
Muc5ac, Muc5b, Muc4, and Gob5 in lungs from wild-type (open bars)
and bENaC-overexpressing (solid bars) mice at birth, 1 week, 3 weeks,
and 6 weeks of age. Data are expressed as fold changes from newborn
wild-type mice. n 5 6–14 mice per group. (A) Muc5ac. *P , 0.001
versus littermate control mice at same age; †P , 0.05 versus newborn,
3-week-old, and 6-week-old wild-type mice; ‡P , 0.05 versus newborn
bENaC-overexpressing mice. (B) Muc5b. *P , 0.01 versus wild-type
mice of same age; †P , 0.05 versus newborn mice of same genotype.
(C) Muc4. *P , 0.001 versus wild-type mice of same age; †P , 0.05
versus wild-type mice of same age; ‡P , 0.05 versus newborn and 1-
week-old wild-type mice; xP , 0.05 versus 1-week-old bENaC-over-
expressing mice. (D) Gob5 expression. *P , 0.05 versus wild-type mice
of same age; †P , 0.05 versus newborn mice of same genotype.
TABLE 1. BLOOD GAS ANALYSIS FROM NEONATAL b-EPITHELIAL NA1 CHANNEL–OVEREXPRESSING MICE AND
WILD-TYPE LITTERMATES*
Genotype pH PCO2 (mm Hg) PO2 (mm Hg) HCO32 (mmol/L) BE (mmol/L) Sat O2 (%)
Wild-type 7.42 6 0.01 48.7 6 1.7 49.9 6 2.0 30.8 6 0.6 5.6 6 0.5 83.7 6 1.8
bENaC overexpressing 7.40 6 0.01 48.8 6 1.4 43.1 6 2.4† 29.2 6 0.6 3.8 6 0.5† 77.0 6 2.4†
Definition of abbreviations: BE 5 base excess; bENaC 5 b-epithelial Na1 channel; Sat O2 5 O2 saturation.
* n 5 8–14 mice per group.
† P , 0.05 compared with littermate control mice.
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reaction toYm1 was minimal or absent in the lungs of newborn
mice, strongest in 3-week-old mice, and waned in adult bENaC-
overexpressing mice. Moreover, Western blot analysis revealed
increased levels of AMCase in BALF harvested from adult
bENaC-overexpressing mice in comparison to wild-type litter-
mates (Figure 8E).
To further elucidate the role of Ym1, Ym2, and AMCase in
ASL depletion–induced airway inflammation, we determined their
longitudinal mRNA expression profiles in lungs from newborn
to adult bENaC-overexpressing mice and control mice (Figures
8F–8H). Ym1 transcript levels increased continuously with age in
wild-type mice and were significantly increased from the age of 3
weeks in bENaC-overexpressing animals (Figure 8F). In contrast
to sustained expression of Ym1, Ym2 transcript levels were only
transiently induced in wild-type littermates, with peak levels at
3 weeks and waning in adult mice (Figure 8G). Similar to Ym1,
Ym2 expression was significantly increased in 3- and 6-week-old
bENaC-overexpressing mice compared with control mice. AMCase
expression was not regulated during development in wild-type mice
but was significantly increased in 3-week-old and older bENaC-
overexpressing mice (Figure 8H). These studies demonstrate that
the expression of all three chitinase family members was signifi-
cantly increased in airway inflammation induced by ASL volume
depletion. However, their distinct temporal regulation in lungs from
wild-type and bENaC-overexpressing mice suggests that Ym1,
Ym2, and AMCase may have unique functions in pulmonary
homeostasis and in the pathogenesis of airway disease.
Na1 Hyperabsorption Is Associated with Emphysema
Because distal airspaces were enlarged in lungs from adult
bENaC-overexpressing mice (11), we performed quantitative
longitudinal studies on lung volumes and mean linear intercepts
as a parameter for alveolar diameter in lungs ranging from neo-
natal to adult bENaC-overexpressing and control mice. In histol-
ogic sections, alveolar size and architecture were normal at birth,
but alveoli were substantially enlarged in 3-week-old and adult
bENaC-overexpressing mice versus control mice (Figures 9A–9D).
Similarly, lung volumes were normal in bENaC-overexpressing
neonates (PN 5) but were increased significantly relative to
control mice at the age of 3 weeks and remained enlarged in
Figure 5. Hypoxia of airway epithelia in neonatal b-epithelial Na1
channel (bENaC)-overexpressing mice. Tissue hypoxia was determined
by injection of 3-day-old neonatal mice with the hypoxia probe
pimonidazole hydrochloride, and subsequent immunostaining of lung
sections with an antibody that detects the probe in hypoxic cells and
evaluation by confocal microscopy. Images depict differential interfer-
ence contrast microscopy (DIC) (left panels) and fluorescein isothiocya-
nate planes (right panels) of lung sections from bENaC-overexpressing
(A) and wild-type (B) mice. Specific immunoreactive signals were ob-
served in the epithelial cells lining the airways of bENaC-overexpressing
mice, but not in wild-type lungs (right panels). Asterisks indicate the
position of the airway lumen. Scale bar, 100 mm.
Figure 4. Epithelial degeneration and necrosis in airways of neonatal
b-epithelial Na1 channel (bENaC)–overexpressing mice. (A, B) Histology
(hematoxylin and eosin) of bronchi from 3-day-old wild-type (A) and
bENaC-overexpressing (B) mice showing hydropic degeneration of
airwayepithelial cells in bENaC-overexpressing mice (arrows). AL 5 airway
lumen; BV 5 blood vessel; scale bars, 50 mm. (C) Time course of
degenerative Clara cells in bronchi of wild-type (open bars) and bENaC-
overexpressing (solid bars) mice at birth, 3 days, 2 weeks, and 6 weeks of
age. n 5 4–12 mice per group. *P , 0.05 versus wild-type mice of same
age; †P , 0.001 versus wild-type mice of same age; ‡P , 0.05 versus
newborn, 2-week-old, and 6-week-old bENaC-overexpressing mice. (D)
Reduced epithelial glycogen, as determined by volume density mea-
surements of periodic acid-Schiff–positive glyconen in newborn bENaC-
overexpressing (solidbars) comparedwithwild-type (openbars)mice.n5 4–
5 mice per group. *P , 0.001 versus littermate control mice. (E–H) Trans-
mission electron microscopy of airway epithelia in bronchi from newborn (E,
F) and 3-day-old (G, H), wild-type (E, G), and bENaC-overexpressing mice
(F, H). (F) Loss of intracellular glycogen (gly) and endoplasmatic reticulum
vacuolarization (vac) in Clara cells (cc) but not in ciliated cells (ci) from
newborn bENaC-overexpressing mice. (H) Pyknotic nuclei (pn) as a sign of
necrosis in Clara cells from 3-day-old bENaC-overexpressing mice. Scale
bars, 10 mm. Representative for n 5 4–12 mice per group.
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adult bENaC-overexpressing mice compared with control mice
(Figure 9E). Mean linear intercepts were normal at birth but
failed to become smaller in 3- and 6-week-old bENaC-over-
expressing mice (Figure 9F).
Assessment of pulmonary mechanics by invasive pulmonary
function testing in adult mice revealed that the dynamic compli-
ance was significantly increased in adult bENaC-overexpressing
mice compared with control mice (Figure 9H). Pressure–
volume curves were also shifted to the left in adult bENaC-
overexpressing mice, reflecting a significantly increased static
compliance compared with wild-type littermates (Figures 9I and
9J). Taken together, these morphologic and functional data
demonstrate that ASL depletion causes pulmonary emphysema
that evolves in parallel to airway mucus obstruction and in-
flammation in bENaC-overexpressing mice.
DISCUSSION
This longitudinal characterization of the evolution of lung disease
in bENaC-overexpressing mice in vivo revealed sequential patho-
genetic events in airways disease caused by airway Na1 hyper-
absorption and ASL dehydration. Our morphometric studies
defined severe airway mucus obstruction in the first days of life
as the earliest and death-causing lesion in bENaC-overexpressing
mice. The initial mucus plugging was restricted to the trachea and
occurred in the absence of goblet cell metaplasia and elevated
mucin gene expression compared with wild-type mice (see Figures
1–3,,). These results indicate that Na1 hyperabsorption-induced
mucus accumulation was caused by deficient clearance of consti-
tutively secreted mucus and demonstrate that ASL depletion
alone (i.e., in the absence of mucus hypersecretion) is sufficient
to cause severe airway mucus obstruction with airflow limitation
resulting in systemic hypoxia and pulmonary mortality.
The striking similarity between initial mucus plugging in
bENaC-overexpressing neonatal mice and infants with CF (27),
both exhibiting severe mucus plugging in the absence of goblet
cell metaplasia and mucus hypersecretion, indicates that de-
hydration of airway surfaces may be sufficient to cause severe
airway obstruction in the human lung. The regional differences
in initial mucus plug formation between bENaC-overexpressing
Figure 6. Development of airway inflammation in b-epithelial Na1 channel (bENaC)-overexpressing mice. (A–E) Bronchoalveolar lavage cell counts
from wild-type (open bars) and bENaC-overexpressing (solid bars) mice at 5 days, 2 weeks, 3 weeks, and 6 weeks of age. n 5 7–20 mice per group.
(A) Total cells. *P , 0.001 versus wild-type mice of same age; †P , 0.05 versus 5-day-old and 6-week-old wild-type mice; ‡P , 0.05 versus 5-day-old
and 2-week-old bENaC-overexpressing mice. (B) Macrophages. *P , 0.01 versus wild-type mice of same age; †P , 0.05 versus 5-day-old and 6-
week-old wild-type mice; ‡P , 0.05 versus 5-day-old, 2-week-old, and 3-week-old bENaC-overexpressing mice. (C) Neutrophils. *P , 0.001 versus
wild-type mice of same age; †P , 0.05 versus 5-day-old bENaC-overexpressing mice. (D) Eosinophils. *P , 0.001 versus wild-type mice of same age;
†P , 0.05 versus 5-day-old and 6-week-old mice of same genotype. (E) Lymphocytes. *P 5 0.02 versus wild-type mice of same age. (F–I)
Bronchoalveolar macrophages were enlarged (F) and morphologically activated in 2-week-old (H) and 6-week-old (I) bENaC-overexpressing mice
compared with wild-type littermates (G) (May-Grünwald-Giemsa staining; scale bars, 50 mm). *P , 0.01 versus littermate control mice.
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mice and patients with CF, in whom mucus plugging is not
restricted to the trachea but is observed initially in the small
airways, may reflect species differences in the anatomic struc-
ture of the tracheobronchial tree. In mice, due to the paucity of
airway branching, the narrowest cross-sectional surface area of
the tracheobronchial tree is found at the level of the trachea,
whereas the extensive branching of human airways produces
significant restrictions in surface area at the level of the terminal
bronchiole (28). Accordingly, the locus of initial mucus plaque
formation in infants with CF and neonatal bENaC-overexpress-
ing mice is consistent with the concept that ASL volume
depletion–induced mucus obstruction occurs in regions of the
tracheobronchial tree with critical reductions of total airway
caliber. Alternatively, the observed differences in localization
of early mucus plugging between patients with CF and bENaC-
overexpressing mice may be related to regional differences in
relative expression of abnormal Na1 transport, goblet cell
numbers, and/or mucin secretory rates.
The histopathologic search for early changes in the intra-
pulmonary airways revealed that epithelial cells of bENaC-
overexpressing neonates were depleted of glycogen stores and
that a subset of cells subsequently underwent hydropic degener-
ation and necrosis in the absence of detectable intrapulmonary
mucus obstruction (Figure 4). The following observations suggest
that epithelial necrosis is a direct consequence of increased
airway Na1 absorption. First, glycogen depletion and epithelial
degeneration were confined to CCSP-positive Clara cells (i.e., the
cell type in which CCSP-driven overexpression of bENaC was
induced). Second, epithelial degeneration was not observed in
airways from mice that overexpressed aENaC or gENaC and did
not exhibit increased airway Na1 absorption (data not shown).
Third, previous studies in human CF airways demonstrated that
increased airway Na1 absorption caused increased epithelial
energy consumption (29). Collectively, these data suggest that
reduced oxygen tension due to formation of tracheal mucus plugs
in the first days of life (see Figure 1 and Table 1), coupled with
increased O2 demands of bENaC-overexpressing Clara cells,
produced cellular hypoxia (Figure 5) that resulted in necrotic
degeneration of a susceptible cell population (likely Clara cells)
in bENaC-overexpressing neonates.
We speculate that release of proinflammatory stimuli by ne-
crotic epithelial cells played a key role in the recruitment of mac-
rophages and in the initiation of airway inflammation in neonatal
bENaC-overexpressing mice (Figures 4, 6, and 7). Macrophages
are a major source of TNF-a, which acts as a potent proinflam-
matory cytokine in the lung. Therefore, Na1 hyperabsorption–
induced epithelial necrosis generated a previously unrecognized
trigger for an inflammatory response (30). Such a mechanism
could contribute to early inflammation observed in a number of
infants with CF in the absence of detectable bacterial infection.
Although necrosis is not a commonly mentioned feature of CF
pathogenesis, ultrastructural studies have detected necrotic
debris in the small airways of patients with CF in the absence
of bacterial infection (31).
In addition to macrophage recruitment and elevation of
TNF-a, the initial inflammatory response caused by ASL deple-
tion was dominated by an elevation of airway neutrophils and
the neutrophil chemoattractant KC, as previously described
for adult bENaC-overexpressing mice (11) (Figures 6 and 7).
Juvenile bENaC-overexpressing mice also exhibited a transient
airway eosinophilia and increased expression of the key Th2
signaling molecule IL-13 that was markedly exaggerated as com-
Figure 7. Time course of expression of proinflammatory cytokines in lungs from b-epithelial Na1 channel (bENaC)-overexpressing mice. (A–F)
Expression of tumor necrosis factor (TNF)-a, keratinocyte-derived cytokine (KC), eotaxin-1, IL-13, and IFN-g protein and mRNA in bronchoalveolar
lavage and lung homogenates from fetal, newborn, 5-day-old, 2-week-old, 3-week-old, and 6-week-old wild-type (open bars) and bENaC-
overexpressing (solid bars) mice. Data are expressed as absolute protein concentrations or fold changes of transcript expression normalized newborn
wild-type mice. n 5 5–13 mice per group. (A) TNF-a. *P , 0.01 versus wild-type mice of same age; †P , 0.05 versus newborn bENaC-
overexpressing mice; ‡P , 0.05 versus fetal and newborn bENaC-overexpressing mice. (B) KC. *P , 0.01 versus wild-type mice of same age; †P ,
0.05 versus newborn bENaC-overexpressing mice. (C) Eotaxin-1 mRNA. *P , 0.01 versus wild-type mice of same age; †P , 0.05 versus newborn
and 1-week-old wild-type mice. (D) IL-13. *P , 0.05 versus wild-type mice of same age; †P , 0.05 versus newborn and 5-day-old, bENaC-
overexpressing mice. (E) IL-13 mRNA. *P , 0.05 versus wild-type mice of same age; †P , 0.05 versus newborn and 6-week-old wild-type mice; ‡P ,
0.05 versus newborn bENaC-overexpressing mice. (F) IFN-g mRNA. *P , 0.05 versus newborn wild-type mice; †P , 0.05 versus newborn and
1-week-old mice of same genotype.
Mall, Harkema, Trojanek, et al.: ASL and Chronic Lung Disease 737
pared with wild-type animals (32–34). In wild-type and bENaC-
overexpressing mice, eosinophil numbers in BALF and IL-13
waned with age, followed by an increase in pulmonary mRNA
expression of the Th1 cytokine IFN-g. Consistent with the data of
George and colleagues (23), our data suggest that the immune
system of juvenile wild-type mice during normal development is
temporarily biased/polarized toward a Th2 response (24). To our
knowledge, these are the first data demonstrating that ASL
depletion, in addition to producing chronic airway neutrophilia,
exaggerates Th2-driven airway inflammation in a Th2-biased
host. We propose that ASL depletion impaired clearance of
inhaled airborne allergens and triggered Th2-driven inflamma-
tion in young bENaC-overexpressing mice. Release of IL-13,
which induced expression of eotaxin-1, resulted in the recruit-
ment of eosinophils into the lung (35).
The chronic lung disease in adult bENaC-overexpressing
mice, including airway mucus plugging, goblet cell metaplasia,
epithelial hypertrophy, elevated mucin gene expression, and
airway neutrophilia, persisted after necrotic cells were detect-
able and Th2-dependent mechanisms waned (Figures 2, 3, 6,
and 7). In this context, the present study supports the idea that
ASL depletion–induced goblet cell metaplasia and mucus
hypersecretion are secondary changes that develop in parallel
to, or consequent to, persistent airway inflammation (11, 36, 37).
The mechanisms of persistent neutrophilic inflammation and
goblet cell metaplasia are not known. We previously hypothe-
sized that chronic airway inflammation and mucus hypersecretion
may be perpetuated by a failure to clear inhaled environmental
particles and irritants triggering the release of proinflammatory
chemokines like MIP-2 and KC from macrophages and/or airway
epithelia in bENaC-overexpressing mice (11, 38). We predict that
future studies in which bENaC-overexpressing mice are exposed
to defined intrapulmonary doses of particulates will help to
further elucidate the relative role of air pollution in the patho-
genesis of chronic obstructive lung disease caused by ASL
depletion and reduced mucus clearance.
Figure 8. Pulmonary expression of chitinases in b-epithelial Na1 channel (bENaC)-overexpressing mice. (A) Eosinophilic crystals in airway
epithelium and overlying mucus and intracytoplasmatic material in nonciliated epithelial cells (arrows) in a large-diameter main axial airway from
a bENaC-overexpressing mouse (hematoxylin and eosin). e 5 Epithelium; m 5 mucus, scale bar, 50 mm. (B, C) Immunolocalization with polyclonal
antibody for Ym1 showing strong Ym1 staining in airway mucus, nonciliated epithelial cells, and alveolar macrophages (arrows) of bENaC-
overexpressing mice (B). a 5 Alveoli. (C) In wild-type mice, weak Ym1-positive staining was limited to alveolar macrophages (arrow). Scale bars,
25 mm. (D) Transmission electron microscopy of a macrophage in the airway lumen from a bENaC-overexpressing mouse containing intracellular
electron-dense crystals (arrows). Scale bar, 2.5 mm. (E) Western blot for AMCase in bronchoalveolar lavage from wild-type and bENaC-
overexpressing mice. Upper panel: Membrane stained with Ponceau S to control for equivalent loading (z60 kD band likely represents albumin).
Lower panel: AMCase (molecular weight z52 kD) is more abundant in bronchoalveolar lavage fluid from bENaC-overexpressing mice than in wild-
type littermates. Representative for n 5 6–8 mice per group. (F–H) Expression levels of Ym1, Ym2, and AMCase transcripts in lungs from wild-type
(open bars) and bENaC-overexpressing (solid bars) mice at birth, 1 week, 3 weeks, and 6 weeks of age. Data are expressed as fold changes from
newborn wild-type mice. n 5 6–14 mice per group. (F) Ym1 mRNA. *P , 0.05 versus wild-type mice of same age; †P , 0.05 versus newborn and
1-week-old mice of same genotype; ‡P , 0.05 versus newborn bENaC-overexpressing mice. (G) Ym2 mRNA. *P , 0.001 versus wild-type mice of
same age; †P , 0.05 versus newborn and 6-week-old mice of same genotype. (H) AMCase mRNA. *P , 0.01 versus wild-type mice of same age.
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Chronic airway inflammation in bENaC-overexpressing mice
was also associated with the formation of eosinophilic crystals
and increased expression of various members of a recently iden-
tified family of mammalian chitinases and chitinase-like proteins,
including Ym1, Ym2, and AMCase (18, 19, 25, 26) (Figure 8).
Early studies of these proteins in the lung identified elevated
expression of Ym1 in mouse models with chronic granulomatous
disease, where Ym1 was shown to be a neutrophil granule
protein, and it was suggested that crystal formation was due to
excess neutrophil turnover at sites of inflammation (25). Sub-
sequently, Ym1 was detected in alveolar macrophages from wild-
type mice (39). Recent studies supported the involvement of
these chitinases in airway inflammation by demonstrating that (1)
all three proteins are up-regulated in the context of Th2-driven
airway inflammation, (2) AMCase expression is elevated in lungs
from patients with asthma, and (3) AMCase polymorphisms are
associated with human asthma (19, 26, 40, 41). Because chitin is
expressed in the walls of fungi and parasites and chitinases are
expressed in alveolar macrophages, neutrophils, and the airway
epithelium, it is possible that chitinases take part in the innate
immune defense against these pathogens (42). Conversely, high
expression of chitinases during inflammation may have deleteri-
ous effects, as indicated by studies showing that inhibition of
AMCase activity ameliorates disease severity in murine asthma
models (19). Indeed, precipitation and formation of crystals,
frequently greater that 100 mm in size, in the airways of bENaC-
overexpressing mice may cause mechanical injury of epithelial
cells and phagocytes and thus promote chronic inflammation.
Although the focus of recent studies on the role of chitinases
in airway disease has been on classic Th2-driven inflammatory
models, our studies suggest that alternative stimuli (e.g., dehy-
dration) can promote chitinase crystal formation.
Our longitudinal studies demonstrate for the first time that
increased airway Na1 absorption and ASL depletion cause em-
physema (Figure 9). Although lung volumes, alveolar architec-
ture, and alveolar size were normal in bENaC-overexpressing
neonates, the subsequent increase in lung volume and relative
distal airspace enlargement together with an increase in lung
Figure 9. Development of emphysema in b-epithelial Na1 channel (bENaC)-overexpressing mice. (A–D) Lung histology (hematoxylin and eosin)
from newborn (A, B) and 6-week-old (C, D) wild-type (A, C), and bENaC-overexpressing (B, D) mice. Scale bars, 100 mm. (E, F) Lung volume (E) and
mean linear intercepts (F) in neonatal to adult bENaC-overexpressing mice (solid bars) and wild-type control mice (open bars). n 5 5–12 mice per
group. *P , 0.001 versus wild-type mice of same age. (G) Pulmonary resistance (RL), (H) dynamic compliance (Cdyn), (I ) pressure–volume curves,
and (J) static compliance (Cstat) were measured in adult bENaC-overexpressing mice (solid bars in G, H, and J; circles in I ) and littermate control mice
(open bars in G, H, and J; triangles in I). n 5 8–14 mice per group. *P , 0.001 versus littermate control mice.
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compliance show that bENaC-overexpressing mice develop
emphysema in the first weeks of life.
We speculate that several mechanisms may contribute to the
development of emphysema in vivo in bENaC-overexpressing
mice (Figure 9). First, emphysema in adult bENaC-overexpressing
mice may reflect failure of alveolar septation during develop-
ment. Because overexpression of bENaC under control of the
CCSP promoter is turned on several days before birth (43),
increased pulmonary Na1 absorption in the prenatal period
may cause a slight deflation of the lungs with reduced trans-
pulmonary pressure, which may reduce a stimulus for postnatal
growth of alveolar walls. Second, the observation that lungs
seem to be consistently hyperinflated even in the absence of
constant pressure fixation indicates that early airway mucus
plugging caused persistent air-trapping, which may result in
mechanical overdistention of distal airspaces with irreversible
disruption of alveolar septi, loss of pulmonary elastance, and
alveolar remodeling. Third, it is possible that chronic pulmonary
inflammation contributes to the development of emphysema in
bENaC-overexpressing mice. Several leukocyte-derived pro-
teases, including neutrophil elastase and macrophage elastase,
have been shown to cause emphysema in mice (44–46). Previous
studies demonstrated that overexpression of several proinflam-
matory mediators, including TNF-a and IL-13, in genetically
modified mice causes an imbalance in the pulmonary protease/
antiprotease system and emphysema (47, 48) and indicated that
proteases/antiproteases may play a key role during lung de-
velopment (49). Because TNF-a, IL-13, and neutrophils are
increased and macrophages are morphologically activated in
the lungs of bENaC-overexpressing mice, we speculate that dis-
ruption of the protease/antiprotease balance in the developing
lung may cause ASL depletion–induced emphysema. Although
further dissection of the relative roles of these mechanisms and
their relationship to airway Na1 hyperabsorption is required, it
is noteworthy that emphysema, together with mucus plugging,
constitutes an early and invariable feature in the CF lung (27).
Recent studies indicated that improvement of ASL hydration
by preventive treatment with the specific ENaC blocker ami-
loride can reduce mortality, airway inflammation, and airway
mucus obstruction in bENaC-overexpressing mice (50). Future
studies are required to determine if improved hydration of
airway surfaces can prevent emphysema formation in bENaC-
overexpressing mice.
On the basis of the similarities in the pulmonary phenotype
between adult bENaC-overexpressing mice and chronic bron-
chitis, including airway mucus obstruction, goblet cell metaplasia,
chronic inflammation, and emphysema (51), we speculate that
ASL depletion may play a critical role in the pathogenesis of
reduced mucus clearance observed in the airways of smokers and
patients with chronic bronchitis (52, 53). In contrast to CF, no
intrinsic ion transport abnormalities have been reported in air-
ways from patients with chronic bronchitis. However, cigarette
smoke has been shown to decrease CFTR expression and cAMP-
dependant Cl2 secretion in airway epithelia in vitro and in vivo
(12, 54), providing a mechanism for ASL depletion. Furthermore,
cigarette smoke induces hypersecretion of mucin macromole-
cules. In the presence of limited ion transport compensation (55),
the mucins secreted ‘‘dry’’ onto airway surfaces (56–58) are not
properly hydrated, producing ‘‘secondary’’ ASL depletion. The
ASL depletion consequent to both mechanisms would be pre-
dicted to produce the slow mucus clearance and mucus adhesion
characteristic of COPD (52, 53).
The observation that ASL depletion can cause concomitant
neutrophilic and Th2-driven airway inflammation is remarkable
in the context of the debate over whether COPD and asthma
are distinct disease entities, as proposed by the ‘‘British
hypothesis,’’ or whether they are based on a common etiologic
background, as put forward by the ‘‘Dutch hypothesis’’ (59).
Our results point to the possibility of a single etiologic hy-
pothesis for seemingly diverse chronic obstructive airway dis-
eases, including CF, COPD, and asthma, in which a defect in
mechanical clearance of inhaled particulates, allergens, or
pathogens, caused by primary or secondary ASL depletion,
plays a critical role in disease pathogenesis. In this context, the
interplay between deficient mechanical lung clearance and the
host immune response determines whether a stimulus triggers
a neutrophil-dominated airway disease, a Th2-driven airway
disease, or both.
In summary, the longitudinal evaluation of the spontaneous
course of lung disease in bENaC-overexpressing mice provides
novel insights into the in vivo pathogenesis of chronic obstruc-
tive lung disease. First, we show that ASL depletion is sufficient
to initiate severe airway mucus obstruction in the absence of
goblet cell metaplasia or mucus hypersecretion. Second, we
show that airway mucus plugging/hypoxia is associated with
epithelial necrosis, constituting a mechanism to initiate airway
inflammation in the absence of infection. Third, we demonstrate
that ASL depletion causes exaggerated eosinophilic airway
inflammation in a Th2-biased host. Finally, we show that in-
creased airway Na1 absorption can cause emphysema. Taken
together, these results suggest that deficient airway surface
hydration plays a critical role in the pathogenesis and serves
as a novel therapeutic target in of chronic obstructive pulmo-
nary diseases of different etiologies.
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